info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » Healthcare

Healthcare

Rapid Phenotypic and Automated Antimicrobial Susceptibility Testing Market By Product (Instruments and Systems, Consumables and Reagents, Software and Services); By Application (Bloodstream Infections and Sepsis, Urinary Tract Infections, Respiratory Tract Infections, Hospital-Acquired Infections, Antimicrobial-Resistance Surveillance); By End User (Hospital and Clinical Laboratories, Diagnostic and Reference Laboratories, Public Health Laboratories, Academic and Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Rapid Phenotypic and Automated Antimicrobial Susceptibility Testing (AST) Market: Global Market Intelligence and Strategic Analysis

The Global Rapid Phenotypic and Automated Antimicrobial Susceptibility Testing Market was valued at USD 1.19 billion in 2025 and is proj... Read More

Published Date: JUL-2026 | No Of Pages:190 | $ 4485

Antifungal Agents Market By Drug Class (Azoles and Tetrazoles, Polyenes, Echinocandins, Allylamines, Triterpenoids, Antimetabolites, Other Approved and Pipeline Antifungal Agents), By Route of Administration (Topical, Oral, Intravenous), By Indication (Candidiasis, Aspergillosis, Dermatophytosis and Superficial Mycoses, Cryptococcosis, Mucormycosis, Other Fungal Infections), By End User (Hospitals, Specialty Clinics, Ambulatory and Outpatient Care Centers, Homecare and Retail Pharmacy Users), By Geography, Segment Revenue Estimation, Forecast: 2026–2032

Antifungal Agents Market: From High-Volume Generics to Resistance-Driven Specialty Therapies

The Global Antifungal Agents Market was valued at USD 16.60 billion in 2025 and is projected to reach USD 22.00 billion by 2032, expanding at a CAGR of 4.1% during 2026–... Read More

Published Date: JUL-2026 | No Of Pages:180 | $ 4485

Dual NK1/NK3 Receptor Antagonists Market By Product (Elinzanetant (Lynkuet), Investigational Dual NK1/NK3 Receptor Antagonists); By Application (Menopause-Associated Moderate-to-Severe Vasomotor Symptoms, Adjuvant Endocrine-Therapy-Associated Vasomotor Symptoms); By End User (Primary Care and Gynecology Clinics, Menopause Specialty Clinics, Oncology and Breast Cancer Care Centers, Retail, Mail-Order and Digital Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Dual NK1/NK3 Receptor Antagonists Market: From First Approval to a Billion-Dollar Nonhormonal Therapy Opportunity

The Global Dual NK1/NK3 Receptor Antagonists Market was valued at USD 10 million in 2025 and is projected to reach USD ... Read More

Published Date: JUL-2026 | No Of Pages:188 | $ 4485

Psoriasis & Psoriatic Arthritis Therapeutics Market By Therapy Type (Topical Therapies, Conventional Systemic Drugs, Targeted Oral Therapies, Biologics, Supportive Anti-Inflammatory Therapies), By Drug Class (TNF-Alpha Inhibitors, IL-17/IL-17 Receptor Inhibitors, IL-23/IL-12 & IL-23 Inhibitors, PDE4 Inhibitors, JAK/TYK2 Inhibitors, Corticosteroids, Other Therapies), By Indication (Plaque Psoriasis, Psoriatic Arthritis, Other Psoriasis Types), By Route of Administration (Topical, Oral, Injectable), By End User (Hospitals, Dermatology Clinics, Rheumatology Clinics, Specialty Clinics, Homecare Settings), By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Psoriasis & Psoriatic Arthritis Therapeutics Market: Targeted Treatment, Long-Term Disease Control, and Access Shape Competition

The Global Psoriasis & Psoriatic Arthritis Therapeutics Market was valued at approximately USD 34.8 billion in 2025 and is projecte... Read More

Published Date: JUL-2026 | No Of Pages:162 | $ 4485

Subcutaneous Biologics Market By Molecule Type (Proteins and Peptides, Monoclonal Antibodies, Nucleic Acid-Based Biologics, Enzymes, Other Biologics), By Therapeutic Application (Metabolic Disorders, Autoimmune and Inflammatory Diseases, Oncology, Neurology, Rare Diseases, Other Applications), By Delivery Format (Prefilled Syringes, Autoinjectors, On-Body Delivery Systems, Large-Volume Injectors, Other Delivery Formats), By End User (Home Care Settings, Hospitals, Oncology Centers, Specialty Clinics), By Geography, Segment Revenue Estimation, Forecast: 2026–2032

Subcutaneous Biologics Market: Faster Administration and Home-Based Care Reshape Specialty Medicine

The Global Subcutaneous Biologics Market was valued at USD 124.8 billion in 2025 and is projected to reach approximately USD 219.5 billion by 2032, expanding at a CAGR ... Read More

Published Date: JUL-2026 | No Of Pages:190 | $ 4485

Reconstructed Skin Models Market By Model Type (Reconstructed Human Epidermis [RhE], Full-Thickness Human Skin Equivalents, Advanced and Tri-Layered Skin Models, Pigmented Skin Models, Immune-Competent and Microbiome Skin Models), By Application (Skin Irritation Testing, Skin Corrosion Testing, Phototoxicity Testing, Absorption and Permeation Studies, Cosmetic Efficacy Testing, Disease and Aging Research, Wound-Healing Research), By End User (Cosmetics and Cosmeceutical Companies, Pharmaceutical and Biotechnology Companies, Chemical Manufacturers, Medical-Device Companies, Contract Research Organizations, Academic and Research Institutions), By Geography, Segment Revenue Estimation, Forecast: 2026–2032

Reconstructed Skin Models Market: Regulatory Acceptance and Complex Human Skin Research Support Market Expansion

The Global Reconstructed Skin Models Market was valued at approximately USD 48.0 million in 2025 and is projected to reach approximately <... Read More

Published Date: JUL-2026 | No Of Pages:180 | $ 4485

Microfluidic Drug Delivery Technologies Market By Product (Microfluidic Formulation Platforms, Wearable and On-Body Micro-Pumps, Implantable Microfluidic Drug Delivery Devices); By Application (Diabetes, Oncology, Neurological Disorders, RNA and Genetic Therapies, Other Chronic Diseases); By End User (Pharmaceutical and Biotechnology Companies, Hospitals and Specialty Clinics, Home-Care Settings, Academic and Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Microfluidic Drug Delivery Technologies Market: From Nanoparticle Formulation to Recurring Micro-Pump Revenue

The Global Microfluidic Drug Delivery Technologies Market was valued at USD 2.34 billion in Read More

Published Date: JUL-2026 | No Of Pages:165 | $ 4485

Familial Hypercholesterolemia Treatment Market By Product Type (Statins, Cholesterol Absorption Inhibitors, PCSK9 Inhibitors, siRNA Therapies, ACL Inhibitors, ANGPTL3 Inhibitors, MTP Inhibitors, Combination Therapies, Lipoprotein Apheresis); By Disease Type (Heterozygous Familial Hypercholesterolemia, Homozygous Familial Hypercholesterolemia); By Route of Administration (Oral, Subcutaneous, Intravenous); By End User (Hospitals, Specialty Lipid Clinics, Cardiology Clinics, Infusion Centers, Homecare Settings); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Familial Hypercholesterolemia Treatment Market: Diagnosis Gaps, PCSK9 Competition, and the Shift Toward Long-Acting Therapies

The Global Familial Hypercholesterolemia Treatment Market was valued at USD 2.65 billion ... Read More

Published Date: JUL-2026 | No Of Pages:185 | $ 4485

Mucopolysaccharidosis Treatment Market By Treatment Type (Enzyme Replacement Therapy, Hematopoietic Stem Cell Transplantation, Supportive Care and Symptomatic Treatment, Emerging Gene and Cell Therapies), By Disease Type (MPS I, MPS II, MPS III, MPS IVA, MPS VI, MPS VII, Other MPS Types), By End User (Hospitals, Specialty Clinics, Research and Academic Institutions), By Geography, Segment Revenue Estimation, Forecast: 2026–2032

Microfluidic Drug Delivery Technologies Market: From Nanoparticle Formulation to Recurring Micro-Pump Revenue

The Global Microfluidic Drug Delivery Technologies Market was valued at USD 2.34 billion in Read More

Published Date: JUL-2026 | No Of Pages:190 | $ 4485

Mechanical Venous Thrombectomy Systems Market By Product (Aspiration Thrombectomy Systems, Mechanical Retrieval and Coring Systems, Rheolytic and Pharmacomechanical Thrombectomy Systems, Rotational Thrombectomy Systems, Hybrid Thrombectomy Systems); By Application (Pulmonary Embolism, Deep-Vein Thrombosis); By End User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Mechanical Venous Thrombectomy Systems Market : Procedure Adoption Converts Venous Thromboembolism Burden into Device Revenue

The Global Mechanical Venous Thrombectomy Systems Market was valued at USD 1.05 billion ... Read More

Published Date: JUL-2026 | No Of Pages:169 | $ 4485